gravitate-ips-4
type: Bundle
node role: treeRoot
id:
  v: gravitate-ips-4
meta:
  profile:
    v: http://hl7.org/fhir/uv/ips/StructureDefinition/Bundle-uv-ips
    l: Bundle-uv-ips
identifier:
  system:
    v: https://www.gravitatehealth.eu/sid/doc
    l: doc
  value:
    v: ips-4
type:
  v: document
timestamp:
  v: 2021-09-03T08:38:00+02:00
entry:
  full url:
    v: https://myserver.org/Composition/2fa5b223-ebce-4f39-9c66-5dc014f73579
entry:
  full url:
    v: https://myserver.org/Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd2
entry:
  full url:
    v: https://myserver.org/Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d2
entry:
  full url:
    v: https://myserver.org/AllergyIntolerance/1dff4474-fa08-4f45-8260-dbb23094bf02
entry:
  full url:
    v: https://myserver.org/AllergyIntolerance/9d18cddb-8e58-4fbb-82ec-09cc561ac802
entry:
  full url:
    v: https://myserver.org/Condition/bcc79261-142c-48ec-b032-f3f9af49ec52
entry:
  full url:
    v: https://myserver.org/Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6252
entry:
  full url:
    v: https://myserver.org/Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5132
entry:
  full url:
    v: https://myserver.org/MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a892
entry:
  full url:
    v: https://myserver.org/MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78f2
entry:
  full url:
    v: https://myserver.org/MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87b2
entry:
  full url:
    v: https://myserver.org/MedicationStatement/citalopram-statement
    l: citalopram-statement
  resource: citalopram-statement
entry:
  full url:
    v: https://myserver.org/MedicationStatement/amlo-italy-statement
    l: amlo-italy-statement
  resource: amlo-italy-statement
entry:
  full url:
    v: https://myserver.org/MedicationStatement/amlo-norway-statement
    l: amlo-norway-statement
  resource: amlo-norway-statement
entry:
  full url:
    v: https://myserver.org/Medication/b50ae644-e0b7-4007-809f-26f493cbe362
entry:
  full url:
    v: https://myserver.org/Medication/de131e15-ed13-4b31-b38c-3204a84d99c2
entry:
  full url:
    v: https://myserver.org/Medication/9ac3356c-4ea4-4814-84c3-235484f2ef12
entry:
  full url:
    v: https://myserver.org/Medication/citalopram
    l: citalopram
  resource: citalopram
entry:
  full url:
    v: https://myserver.org/Medication/amlo-italy
    l: amlo-italy
  resource: amlo-italy
entry:
  full url:
    v: https://myserver.org/Medication/amlo-norway
    l: amlo-norway
  resource: amlo-norway
entry:
  full url:
    v: https://myserver.org/Observation/e06e43a1-38d4-468f-8c35-f7f12da91062
entry:
  full url:
    v: https://myserver.org/Observation/bw
    l: bw
  resource: bw
entry:
  full url:
    v: https://myserver.org/Observation/bh
    l: bh
  resource: bh
entry:
  full url:
    v: https://myserver.org/Observation/ips4-bp
    l: ips4-bp
  resource: ips4-bp
entry:
  full url:
    v: https://myserver.org/Observation/glucose
    l: glucose
  resource: glucose
entry:
  full url:
    v: https://myserver.org/Observation/egfr
    l: egfr
  resource: egfr
entry:
  full url:
    v: https://myserver.org/Observation/potassium
    l: potassium
  resource: potassium
entry:
  full url:
    v: https://myserver.org/Observation/QR-EQ5D-5L-Example
    l: QR-EQ5D-5L-Example
  resource: QR-EQ5D-5L-Example
entry:
  full url:
    v: https://myserver.org/Observation/Obs-Health-Literacy-YesNo
    l: Obs-Health-Literacy-YesNo
  resource: Obs-Health-Literacy-YesNo
entry:
  full url:
    v: https://myserver.org/Observation/Obs-Digital-Literacy-Scale
    l: Obs-Digital-Literacy-Scale
  resource: Obs-Digital-Literacy-Scale
entry:
  full url:
    v: https://myserver.org/Observation/physical-activity
    l: physical-activity
  resource: physical-activity

https://myserver.org/Composition/2fa5b223-ebce-4f39-9c66-5dc014f73579
type: Composition
id:
  v: ips-example-4
text:
  status:
    v: extensions
  div:
    v: Id: ips-example-4 status: Final Type: Patient summary Document Subject: Example 4 Gravitate Sections: Allergies and Intolerances Hay fever (pollen) Lactose Intolerance Problem List Psoriasis Hypertension Congestive heart failure Medication Summary Remsima 100 mg powder for concentrate for solution for infusion Irbesartan 75 mg Tablet Pentasa Slow Release Tablets 1g citalopram statement Amlodipine Italy statement Amlodipine Norway statement Vital Signs Body weight Body height Blood pressure eGFR potassium Results glucose Pregnancy History Pregrancy Status Social History Physical Activity Health Literacy Digital Literacy EQ-5D-5L
status:
  v: final
type:
  coding: https://loinc.org/rdf/60591-5
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 60591-5
    display:
      v: Patient summary Document
subject:
  display:
    v: Example 4 Gravitate
date:
  v: 2018-07-10T15:22:00+02:00
author:
  display:
    v: Dr. Anna Karlsson
title:
  v: Patient Summary (IPS Example 4 Gravitate)
confidentiality:
  v: N
section:
  title:
    v: Allergies and Intolerances
  code:
    coding: https://loinc.org/rdf/48765-2
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 48765-2
      display:
        v: Allergies and adverse reactions Document
  entry:
    display:
      v: Hay fever (pollen)
  entry:
    display:
      v: Lactose Intolerance
section:
  title:
    v: Problem List
  code:
    coding: https://loinc.org/rdf/11450-4
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 11450-4
      display:
        v: Problem list Reported
  entry:
    display:
      v: Psoriasis
  entry:
    display:
      v: Hypertension
  entry:
    display:
      v: Congestive heart failure
section:
  title:
    v: Medication Summary
  code:
    coding: https://loinc.org/rdf/10160-0
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 10160-0
      display:
        v: Hx of Medication use
  entry:
    display:
      v: Remsima 100 mg powder for concentrate for solution for infusion
  entry:
    display:
      v: Irbesartan 75 mg Tablet
  entry:
    display:
      v: Pentasa Slow Release Tablets 1g
  entry:
    l: citalopram-statement
    reference:
      v: MedicationStatement/citalopram-statement
    display:
      v: citalopram statement
  entry:
    l: amlo-italy-statement
    reference:
      v: MedicationStatement/amlo-italy-statement
    display:
      v: Amlodipine Italy statement
  entry:
    l: amlo-norway-statement
    reference:
      v: MedicationStatement/amlo-norway-statement
    display:
      v: Amlodipine Norway statement
section:
  title:
    v: Vital Signs
  code:
    coding: https://loinc.org/rdf/8716-3
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 8716-3
      display:
        v: Vital Signs
  entry:
    l: bw
    reference:
      v: Observation/bw
    display:
      v: Body weight
  entry:
    l: bh
    reference:
      v: Observation/bh
    display:
      v: Body height
  entry:
    l: ips4-bp
    reference:
      v: Observation/ips4-bp
    display:
      v: Blood pressure
  entry:
    l: egfr
    reference:
      v: Observation/egfr
    display:
      v: eGFR
  entry:
    l: potassium
    reference:
      v: Observation/potassium
    display:
      v: potassium
section:
  title:
    v: Results
  code:
    coding: https://loinc.org/rdf/30954-2
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 30954-2
      display:
        v: Relevant diagnostic tests/laboratory data Narrative
  entry:
    l: glucose
    reference:
      v: Observation/glucose
    display:
      v: glucose
section:
  title:
    v: Pregnancy History
  code:
    coding: https://loinc.org/rdf/10162-6
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 10162-6
      display:
        v: Pregnancies Hx
  entry:
    display:
      v: Pregrancy Status
section:
  title:
    v: Social History
  code:
    coding: https://loinc.org/rdf/29762-2
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 29762-2
      display:
        v: Social History
  entry:
    l: physical-activity
    reference:
      v: Observation/physical-activity
    display:
      v: Physical Activity

https://myserver.org/Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd2
type: Patient
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Patient c154158f-6a43-4ab7-8443-e7f4bf915dd2 IPS 4 example Gravitate Female, DoB: 1989-05-05 ( https://www.gravitatehealth.eu/sid/doc#ips-4) Active: true Other Id: keycloak-id/370887cf-f2c5-4e07-971a-827397d4ea45 Patient Citizenship: code: Norway
extension:
  extension:
    url:
      v: code
      l: code
    value: CodeableConcept
  url:
    v: http://hl7.org/fhir/StructureDefinition/patient-citizenship
    l: patient-citizenship
extension:
  url:
    v: http://hl7.org/fhir/StructureDefinition/individual-occupation
    l: individual-occupation
  value: CodeableConcept
    coding:
      system:
        v: http://www.ilo.org/public/english/bureau/stat/isco
        l: isco
      code:
        v: 3421
      display:
        v: Athletes and sports players
identifier:
  system:
    v: https://www.gravitatehealth.eu/sid/doc
    l: doc
  value:
    v: ips-4
identifier:
  system:
    v: keycloak-id
    l: keycloak-id
active:
  v: true
name:
  family:
    v: Gravitate
  given:
    v: IPS 4 example
gender:
  v: female
birth date:
  v: 1989-05-05

https://myserver.org/Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d2
type: Practitioner
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Practitioner 1ece89c5-fda3-4db9-ace6-decbe6c603d2 name: Anne Karlsson
name:
  family:
    v: Karlsson
  given:
    v: Anne
  prefix:
    v: Dr.

https://myserver.org/AllergyIntolerance/1dff4474-fa08-4f45-8260-dbb23094bf02
type: AllergyIntolerance
text:
  status:
    v: generated
  div:
    v: Generated Narrative: AllergyIntolerance 1dff4474-fa08-4f45-8260-dbb23094bf02 clinicalStatus: Active verificationStatus: Confirmed type: Allergy category: Environment code: Pollen patient: IPS 4 Gravitate Reactions - Manifestation * Hay fever
clinical status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical
      l: allergyintolerance-clinical
    code:
      v: active
verification status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/allergyintolerance-verification
      l: allergyintolerance-verification
    code:
      v: confirmed
type:
  v: allergy
category:
  v: environment
code:
  coding: http://snomed.info/id/256259004
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 256259004
    display:
      v: Pollen
patient:
  display:
    v: IPS 4 Gravitate
reaction:
  manifestation:
    coding: http://snomed.info/id/21719001
      system:
        v: http://snomed.info/sct
        l: sct
      code:
        v: 21719001
      display:
        v: Allergic rhinitis caused by pollen
    text:
      v: Hay fever

https://myserver.org/AllergyIntolerance/9d18cddb-8e58-4fbb-82ec-09cc561ac802
type: AllergyIntolerance
text:
  status:
    v: generated
  div:
    v: Generated Narrative: AllergyIntolerance 9d18cddb-8e58-4fbb-82ec-09cc561ac802 clinicalStatus: Active verificationStatus: Confirmed type: Intolerance category: Food code: Intolerance to lactose patient: IPS 4 Gravitate onset: 1 year (Details: UCUM codea = 'a') recordedDate: 2009-10-09 reaction substance: lactose manifestation: Abdominal pain, Abdominal bloating, Diarrhea
clinical status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical
      l: allergyintolerance-clinical
    code:
      v: active
verification status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/allergyintolerance-verification
      l: allergyintolerance-verification
    code:
      v: confirmed
type:
  v: intolerance
category:
  v: food
code:
  coding: http://snomed.info/id/782415009
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 782415009
    display:
      v: Intolerance to lactose
patient:
  display:
    v: IPS 4 Gravitate
onset: Age
  value:
    v: 1
  unit:
    v: year
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: a
recorded date:
  v: 2009-10-09
reaction:
  substance:
    coding: http://snomed.info/id/47703008
      system:
        v: http://snomed.info/sct
        l: sct
      code:
        v: 47703008
      display:
        v: lactose
  manifestation:
    coding: http://snomed.info/id/21522001
      system:
        v: http://snomed.info/sct
        l: sct
      code:
        v: 21522001
      display:
        v: Abdominal pain
  manifestation:
    coding: http://snomed.info/id/116289008
      system:
        v: http://snomed.info/sct
        l: sct
      code:
        v: 116289008
      display:
        v: Abdominal bloating
  manifestation:
    coding: http://snomed.info/id/62315008
      system:
        v: http://snomed.info/sct
        l: sct
      code:
        v: 62315008
      display:
        v: Diarrhea

https://myserver.org/Condition/bcc79261-142c-48ec-b032-f3f9af49ec52
type: Condition
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Condition bcc79261-142c-48ec-b032-f3f9af49ec52 clinicalStatus: Active code: Psoriasis subject: IPS 4 Gravitate asserter: Dr. Anna Karlsson
clinical status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/condition-clinical
      l: condition-clinical
    code:
      v: active
code:
  coding: http://snomed.info/id/9014002
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 9014002
    display:
      v: Psoriasis
  text:
    v: Psoriasis
subject:
  display:
    v: IPS 4 Gravitate
asserter:
  display:
    v: Dr. Anna Karlsson

https://myserver.org/Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6252
type: Condition
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Condition a4a9d90a-d1b0-4d60-82f0-c52343dc6252 clinicalStatus: Active code: Congestive heart failure subject: IPS 4 Gravitate onset: 2015 asserter: Dr. Anna Karlsson
clinical status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/condition-clinical
      l: condition-clinical
    code:
      v: active
code:
  coding: http://snomed.info/id/42343007
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 42343007
    display:
      v: Congestive heart failure
  text:
    v: Congestive heart failure
subject:
  display:
    v: IPS 4 Gravitate
onset: DateTime
  v: 2015
asserter:
  display:
    v: Dr. Anna Karlsson

https://myserver.org/Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5132
type: Condition
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Condition f06b7cf8-c15c-4288-a0f9-45a1026e5132 clinicalStatus: Active code: Hypertension subject: IPS 4 Gravitate onset: 1993
clinical status:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/condition-clinical
      l: condition-clinical
    code:
      v: active
code:
  coding: http://snomed.info/id/38341003
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 38341003
    display:
      v: HT - Hypertension
  text:
    v: Hypertension
subject:
  display:
    v: IPS 4 Gravitate
onset: DateTime
  v: 1993

https://myserver.org/MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a892
type: MedicationStatement
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement 29074ca4-efcb-4ff4-8446-feed2399a892 status: Active medication: Remsima 100 mg powder for concentrate for solution for infusion subject: IPS 4 Gravitate Dosages - Route * Intravenous use
status:
  v: active
medication: Reference
  display:
    v: Remsima 100 mg powder for concentrate for solution for infusion
subject:
  display:
    v: IPS 4 Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20045000
      display:
        v: Intravenous use

https://myserver.org/MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78f2
type: MedicationStatement
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement f6cb1218-f81c-4338-80d8-3c10910f78f2 status: Active medication: Karvea 75 mg Tablet subject: IPS 4 Gravitate Dosages - Route * Oral use
status:
  v: active
medication: Reference
  display:
    v: Karvea 75 mg Tablet
subject:
  display:
    v: IPS 4 Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20053000
      display:
        v: Oral use

https://myserver.org/MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87b2
type: MedicationStatement
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement f26084c9-b1c8-46d9-acb2-1d400ade87b2 status: Active medication: Humalog 100 U/ml 5 pre-filled pen subject: IPS 4 Gravitate Dosages - Route * Subcutaneous use
status:
  v: active
medication: Reference
  display:
    v: Humalog 100 U/ml 5 pre-filled pen
subject:
  display:
    v: IPS 4 Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20066000
      display:
        v: Subcutaneous use

citalopram-statement
type: MedicationStatement
id:
  v: citalopram-statement
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement citalopram-statement status: Active medication: citalopram subject: IPS 4 Gravitate Dosages - Route * Subcutaneous use
status:
  v: active
medication: Reference
  l: citalopram
  reference:
    v: Medication/citalopram
  display:
    v: citalopram
subject:
  display:
    v: IPS 4 Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20066000
      display:
        v: Subcutaneous use

amlo-italy-statement
type: MedicationStatement
id:
  v: amlo-italy-statement
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement amlo-italy-statement status: Active medication: Amlodipine Italy subject: IPS 4 Gravitate Dosages - Route * Oral use
status:
  v: active
medication: Reference
  l: amlo-italy
  reference:
    v: Medication/amlo-italy
  display:
    v: Amlodipine Italy
subject:
  display:
    v: IPS 4 Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20053000
      display:
        v: Oral use

amlo-norway-statement
type: MedicationStatement
id:
  v: amlo-norway-statement
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicationStatement amlo-norway-statement status: Active medication: Amlodipine Norway subject: IPS 4 Gravitate Dosages - Route * Oral use
status:
  v: active
medication: Reference
  l: amlo-norway
  reference:
    v: Medication/amlo-norway
  display:
    v: Amlodipine Norway
subject:
  display:
    v: IPS 4 Gravitate
dosage:
  route:
    coding:
      system:
        v: http://standardterms.edqm.eu
        l: standardterms.edqm.eu
      code:
        v: 20053000
      display:
        v: Oral use

https://myserver.org/Medication/b50ae644-e0b7-4007-809f-26f493cbe362
type: Medication
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication b50ae644-e0b7-4007-809f-26f493cbe362 code: Remsima 100 mg powder for concentrate for solution for infusion form: Powder for concentrate for solution for injection/infusion Ingredients - Item[x] Strength * INFLIXIMAB 100 mg (Details: UCUM codemg = 'mg')/1 Vial (Details: UCUM code{vial} = '{vial}')
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: EU/1/13/853/001
    display:
      v: Remsima 100 mg powder for concentrate for solution for infusion
  coding:
    system:
      v: https://www.who-umc.org/phpid
      l: phpid
    code:
      v: 0xF79CABF272B6A7EEF104DDDA44E82718
    display:
      v: Infliximab 100 mg powder for concentrate for solution for infusion
form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 50049250
    display:
      v: Powder for concentrate for solution for injection/infusion
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: B72HH48FLU
      display:
        v: INFLIXIMAB
    text:
      v: INFLIXIMAB
  strength:
    numerator:
      value:
        v: 100
      unit:
        v: mg
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg
    denominator:
      value:
        v: 1
      unit:
        v: Vial
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: {vial}

https://myserver.org/Medication/de131e15-ed13-4b31-b38c-3204a84d99c2
type: Medication
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication de131e15-ed13-4b31-b38c-3204a84d99c2 code: Karvea 75 mg/ 1 tablet, Tablet form: Tablet Ingredients - Item[x] Strength * irbesartan 75 mg (Details: UCUM codemg = 'mg')/1 Tablet (Details: UCUM code{tablet} = '{tablet}')
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: EU/1/97/049/001
    display:
      v: Karvea 75 mg/ 1 tablet, Tablet
  coding:
    system:
      v: https://www.who-umc.org/phpid
      l: phpid
    code:
      v: 0xF79CABF272B6A7EEF104DDDA44E82719
    display:
      v: Irbesartan, 75 mg/ 1 tablet, Tablet
  coding:
    system:
      v: http://www.whocc.no/atc
      l: atc
    code:
      v: C09DA04
    display:
      v: irbesartan and diuretics
form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 10219000
    display:
      v: Tablet
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: J0E2756Z7N
      display:
        v: irbesartan
    text:
      v: irbesartan
  strength:
    numerator:
      value:
        v: 75
      unit:
        v: mg
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg
    denominator:
      value:
        v: 1
      unit:
        v: Tablet
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: {tablet}

https://myserver.org/Medication/9ac3356c-4ea4-4814-84c3-235484f2ef12
type: Medication
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication 9ac3356c-4ea4-4814-84c3-235484f2ef12 code: Humalog Mix50 KwikPen 100 U/ml 5 pre-filled pen form: Suspension for injection Ingredients - Item[x] Strength * Insulin Lispro 100 U (Details: UCUM codeU = 'U')/1 ml (Details: UCUM codeml = 'ml')
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: EU/1/96/007/035
    display:
      v: Humalog Mix50 KwikPen 100 U/ml 5 pre-filled pen
  coding:
    system:
      v: https://www.who-umc.org/phpid
      l: phpid
    code:
      v: 0xF79CABF272B6A7EEF104DDDA44E82717
    display:
      v: Insulin Lispro 100 U/ml 5 pre-filled pen
form:
  coding:
    system:
      v: http://standardterms.edqm.eu
      l: standardterms.edqm.eu
    code:
      v: 11202000
    display:
      v: Suspension for injection
  text:
    v: Suspension for injection
ingredient:
  item: CodeableConcept
    coding:
      system:
        v: http://fdasis.nlm.nih.gov
        l: fdasis.nlm.nih.gov
      code:
        v: GFX7QIS1II
      display:
        v: Insulin Lispro
    text:
      v: Insulin Lispro
  strength:
    numerator:
      value:
        v: 100
      unit:
        v: U
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: U
    denominator:
      value:
        v: 1
      unit:
        v: ml
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: ml

citalopram
type: Medication
id:
  v: citalopram
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication citalopram code: Citalopram Aurovitas 10 mg tablet
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: 204447
    display:
      v: Citalopram Aurovitas 10 mg tablet

amlo-italy
type: Medication
id:
  v: amlo-italy
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication amlo-italy code: AMLODIPINA DOC GENERICI compresse 10 mg
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: AMLODIPINA-DOC-GENERICI-tablet-10mg--71-ITA-MPD
    display:
      v: AMLODIPINA DOC GENERICI compresse 10 mg

amlo-norway
type: Medication
id:
  v: amlo-norway
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Medication amlo-norway code: Amlodipin sandoz 10 mg TABLETTER
code:
  coding:
    system:
      v: https://spor.ema.europa.eu/pmswi
      l: pmswi
    code:
      v: AMLODIPINA-SANDOZ-tablet-10mg--3-NO-MPD
    display:
      v: Amlodipin sandoz 10 mg TABLETTER

https://myserver.org/Observation/e06e43a1-38d4-468f-8c35-f7f12da91062
type: Observation
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation e06e43a1-38d4-468f-8c35-f7f12da91062 status: Final code: Pregnancy status subject: IPS 4 Gravitate effective: 2020-01-10 value: Pregnant
status:
  v: final
code:
  coding: https://loinc.org/rdf/82810-3
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 82810-3
    display:
      v: Pregnancy status
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2020-01-10
value: CodeableConcept
  coding: LA15173-0
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: LA15173-0
    display:
      v: Pregnant

bw
type: Observation
id:
  v: bw
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation bw status: Final category: Vital Signs code: Body weight subject: IPS 4 Gravitate effective: 2009-10-09 value: 70 kg (Details: UCUM codekg = 'kg')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/29463-7
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 29463-7
    display:
      v: Body weight
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2009-10-09
value: Quantity
  value:
    v: 70
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: kg

bh
type: Observation
id:
  v: bh
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation bh status: Final category: Vital Signs code: Body height subject: IPS 4 Gravitate effective: 2009-10-09 value: 170 cm (Details: UCUM codecm = 'cm')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/8302-2
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 8302-2
    display:
      v: Body height
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2009-10-09
value: Quantity
  value:
    v: 170
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: cm

ips4-bp
type: Observation
id:
  v: ips4-bp
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation ips4-bp status: Final category: Vital Signs code: Blood pressure panel with all children optional subject: IPS 4 Gravitate effective: 2009-10-09 component code: Diastolic blood pressure value: 80 mm[Hg] (Details: UCUM codemm[Hg] = 'mm[Hg]') component code: Systolic blood pressure value: 120 mm[Hg] (Details: UCUM codemm[Hg] = 'mm[Hg]')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/85354-9
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 85354-9
    display:
      v: Blood pressure panel with all children optional
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2009-10-09
component:
  code:
    coding: https://loinc.org/rdf/8462-4
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 8462-4
      display:
        v: Diastolic blood pressure
  value: Quantity
    value:
      v: 80
    system:
      v: http://unitsofmeasure.org
      l: unitsofmeasure.org
    code:
      v: mm[Hg]
component:
  code:
    coding: https://loinc.org/rdf/8480-6
      system:
        v: http://loinc.org
        l: loinc.org
      code:
        v: 8480-6
      display:
        v: Systolic blood pressure
  value: Quantity
    value:
      v: 120
    system:
      v: http://unitsofmeasure.org
      l: unitsofmeasure.org
    code:
      v: mm[Hg]

glucose
type: Observation
id:
  v: glucose
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation glucose status: Final category: Vital Signs code: Glucose [Moles/volume] in Blood subject: IPS 4 Gravitate effective: 2013-04-02 09:30:10+0100 value: 6.3 mmol/l (Details: UCUM codemmol/L = 'mmol/L') interpretation: High ReferenceRanges - Low High * 3.1 mmol/l (Details: UCUM codemmol/L = 'mmol/L') 6.2 mmol/l (Details: UCUM codemmol/L = 'mmol/L')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/15074-8
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 15074-8
    display:
      v: Glucose [Moles/volume] in Blood
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2013-04-02T09:30:10+01:00
value: Quantity
  value:
    v: 6.3
  unit:
    v: mmol/l
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: mmol/L
interpretation:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation
      l: v3-ObservationInterpretation
    code:
      v: H
    display:
      v: High
reference range:
  low:
    value:
      v: 3.1
    unit:
      v: mmol/l
    system:
      v: http://unitsofmeasure.org
      l: unitsofmeasure.org
    code:
      v: mmol/L
  high:
    value:
      v: 6.2
    unit:
      v: mmol/l
    system:
      v: http://unitsofmeasure.org
      l: unitsofmeasure.org
    code:
      v: mmol/L

egfr
type: Observation
id:
  v: egfr
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation egfr status: Final category: Vital Signs code: Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M among black population subject: IPS 4 Gravitate effective: 2013-04-02 09:30:10+0100 value: 29 mL/min/1.73m2 (Details: UCUM codemL/min/1.73m2 = 'mL/min/1.73m2')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/48643-1
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 48643-1
    display:
      v: Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M among black population
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2013-04-02T09:30:10+01:00
value: Quantity
  value:
    v: 29
  unit:
    v: mL/min/1.73m2
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: mL/min/1.73m2

potassium
type: Observation
id:
  v: potassium
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation potassium status: Final category: Vital Signs code: Potassium [Moles/volume] in Blood subject: IPS 4 Gravitate effective: 2013-04-02 09:30:10+0100 value: 2.5 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: vital-signs
code:
  coding: https://loinc.org/rdf/6298-4
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 6298-4
    display:
      v: Potassium [Moles/volume] in Blood
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2013-04-02T09:30:10+01:00
value: Quantity
  value:
    v: 2.5
  unit:
    v: mmol/L
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: mmol/L

QR-EQ5D-5L-Example
type: QuestionnaireResponse
id:
  v: QR-EQ5D-5L-Example
text:
  status:
    v: generated
  div:
    v: Generated Narrative: QuestionnaireResponse QR-EQ5D-5L-Example LinkID Text Definition Answer<img src="[binary]" alt="doco" style="background-color: inherit"/> QR-EQ5D-5L-Example Questionnaire:EQ-5D-5L #xD; d1 EQ-5D-5L Levels: 2 (Slight problems) #xD; d2 EQ-5D-5L Levels: 1 (No problems) #xD; d3 EQ-5D-5L Levels: 3 (Moderate problems) #xD; d4 EQ-5D-5L Levels: 2 (Slight problems) #xD; d5 EQ-5D-5L Levels: 1 (No problems) #xD; vas 78 #xD; <img src="[binary]" alt="doco" style="background-color: inherit"/> Documentation for this format
questionnaire:
  v: http://hl7.eu/fhir/ig/gravitate-health-ips/Questionnaire/Questionnaire-EQ5D-5L
  l: Questionnaire-EQ5D-5L
status:
  v: completed
subject:
  display:
    v: IPS 4 Gravitate
authored:
  v: 2025-10-08T10:35:00Z
item:
  link id:
    v: d1
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 2
      display:
        v: Slight problems
item:
  link id:
    v: d2
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 1
      display:
        v: No problems
item:
  link id:
    v: d3
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 3
      display:
        v: Moderate problems
item:
  link id:
    v: d4
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 2
      display:
        v: Slight problems
item:
  link id:
    v: d5
  answer:
    value: Coding
      system:
        v: http://hl7.eu/fhir/ig/gravitate-health-ips/CodeSystem/eq5d-levels-cs
        l: eq5d-levels-cs
      code:
        v: 1
      display:
        v: No problems
item:
  link id:
    v: vas
  answer:
    value: Integer
      v: 78

Obs-Health-Literacy-YesNo
type: Observation
id:
  v: Obs-Health-Literacy-YesNo
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Obs-Health-Literacy-YesNo status: Final category: Social History code: Health literacy (self-reported) subject: IPS 4 Gravitate effective: 2025-10-08 value: Yes
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: social-history
code:
  coding:
    system:
      v: http://example.org/fhir/CodeSystem/literacy
      l: literacy
    code:
      v: health-literacy
    display:
      v: Health literacy (self-reported)
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2025-10-08
value: CodeableConcept
  coding:
    system:
      v: http://example.org/fhir/CodeSystem/literacy
      l: literacy
    code:
      v: yes
    display:
      v: Yes

Obs-Digital-Literacy-Scale
type: Observation
id:
  v: Obs-Digital-Literacy-Scale
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation Obs-Digital-Literacy-Scale status: Final category: Social History code: Digital literacy (self-reported) subject: IPS 4 Gravitate effective: 2025-10-08 value: 2 interpretation: Medium
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: social-history
code:
  coding:
    system:
      v: http://example.org/fhir/CodeSystem/literacy
      l: literacy
    code:
      v: digital-literacy
    display:
      v: Digital literacy (self-reported)
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2025-10-08
value: Integer
  v: 2
interpretation:
  coding:
    system:
      v: http://example.org/fhir/CodeSystem/literacy
      l: literacy
    code:
      v: medium
    display:
      v: Medium

physical-activity
type: Observation
id:
  v: physical-activity
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Observation physical-activity status: Final category: Activity code: Physical activity level subject: IPS 4 Gravitate effective: 2013-04-02 09:30:10+0100 value: Moderately active physical exercise level
status:
  v: final
category:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/observation-category
      l: observation-category
    code:
      v: activity
    display:
      v: Activity
code:
  coding: https://loinc.org/rdf/89555-7
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 89555-7
    display:
      v: Physical activity level
subject:
  display:
    v: IPS 4 Gravitate
effective: DateTime
  v: 2013-04-02T09:30:10+01:00
value: CodeableConcept
  coding: http://snomed.info/id/228400000
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 228400000
    display:
      v: Moderately active physical exercise level

l: Obs-Health-Literacy-YesNo
reference:
  v: Observation/Obs-Health-Literacy-YesNo
display:
  v: Health Literacy

l: Obs-Digital-Literacy-Scale
reference:
  v: Observation/Obs-Digital-Literacy-Scale
display:
  v: Digital Literacy

l: QR-EQ5D-5L-Example
reference:
  v: QuestionnaireResponse/QR-EQ5D-5L-Example
display:
  v: EQ-5D-5L

v: urn:iso:std:iso:3166
l: 3166

v: NO

v: Norway